POINT - Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain
Unknown statusNot applicableNCT05828121
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The investigators do research on chronic pain treatment to minimize the risks associated with opioids.
Study details
- Official title
- Preventing an Opioid Epidemic in Norway: Focusing on Treatment of Chronic Pain
- Conditions
- Interventions
- Behavioral: POINT1
- Sponsor
- Helse Stavanger HF
- Collaborators
- The Research Council of Norway
- Start date
- 2022-10-01
- Primary completion
- 2024-06-01
- Sex
- All
- Age range
- from 18 Years to 67 Years
- Results posted
- No results posted in this snapshot
- Countries
- Norway
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * non-malignant, chronic pain * Registered in Stavanger municipality * Consent to participation. * Age 18 - 67 years * Pain duration \<10 years Exclusion Criteria: * malignant pain condition
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05828121